| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/31/2003 | US20030143527 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis B viral DNA |
| 07/31/2003 | US20030143526 Recombinanr hhv8 dna |
| 07/31/2003 | US20030143525 Methods for nucleic acid manipulation |
| 07/31/2003 | US20030143522 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 07/31/2003 | US20030143266 Combining cationic lipid with polyethyleneglycol derivative to produce homogeneous micellar lipids; combining with biologically active molecule to form micellar complexes |
| 07/31/2003 | US20030143248 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 07/31/2003 | US20030143245 Multivalent streptococcal vaccine compositions and methods for use |
| 07/31/2003 | US20030143244 For preparation of D-amino acids starting from 5'-substituted hydantoins |
| 07/31/2003 | US20030143243 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/31/2003 | US20030143241 For inhibiting hepatitis E virus (HEV) infection |
| 07/31/2003 | US20030143234 For therapy of microbial organism infection |
| 07/31/2003 | US20030143233 For use in diagnosis, therapy |
| 07/31/2003 | US20030143224 Antibodies specific for ungulate PrP |
| 07/31/2003 | US20030143218 As target for drug screening |
| 07/31/2003 | US20030143217 For therapy of smooth muscle cell hyperplasia; cancer therapy |
| 07/31/2003 | US20030143216 For therapy of fungal infections; for detecting chitin, binding chitin |
| 07/31/2003 | US20030143212 Corneal cells expressing active agents and methods of use thereof |
| 07/31/2003 | US20030143209 For gene therapy of cancers or cardiovascular conditions |
| 07/31/2003 | US20030143206 Increasing the level of at least one isoform of the enzyme nitric oxide synthase in the cells of the ano-rectal region for therapy of anal disease |
| 07/31/2003 | US20030143205 Alphavirus expression systems |
| 07/31/2003 | US20030143204 Making the inhibitor consisting of an RNA function inhibiting sequence that is specific to expressible nucleic acid sequence in mammal; inserting the inhibitor into a vessel in the mammal; delivering function inhibiting sequence to a cell |
| 07/31/2003 | US20030143203 Tumor therapy |
| 07/31/2003 | US20030143202 Anemia |
| 07/31/2003 | US20030143200 Porcine adenovirus E1 region |
| 07/31/2003 | US20030143198 Method for preparing a physiologically active il-18 polypeptide |
| 07/31/2003 | US20030143192 Chemokine beta-7 |
| 07/31/2003 | US20030143190 For modulating the immune system; therapy of cancer |
| 07/31/2003 | US20030143156 Prevents non- specific binding of the catalytic species to the support; high catalytic activity and permits easy separation and recovery of the catalytic species for reuse |
| 07/31/2003 | US20030143131 Device for chemical and biochemical reactions using photo-generated reagents |
| 07/31/2003 | US20030143114 Microanalysis device |
| 07/31/2003 | CA2829859A1 Multiply-substituted protease variants |
| 07/31/2003 | CA2732012A1 Genetic sequences having methyltransferase activity and uses therefor |
| 07/31/2003 | CA2511229A1 Methods for multiple parameter screening and evolution of cells to produce small molecules with multiple functionalities |
| 07/31/2003 | CA2510751A1 Multimers of receptor-binding ligands |
| 07/31/2003 | CA2486588A1 Method for the production of resveratrol in cell cultures |
| 07/31/2003 | CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar |
| 07/31/2003 | CA2474766A1 Stem cell maturation for all tissue types |
| 07/31/2003 | CA2474763A1 Fiber shaft modifications for efficient targeting |
| 07/31/2003 | CA2474623A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 07/31/2003 | CA2474353A1 Method for screening a drug ameliorating insulin resistance |
| 07/31/2003 | CA2474344A1 Expansion of renewable stem cell populations |
| 07/31/2003 | CA2474259A1 Antibodies against and compositions containing new amphetamine derivatives |
| 07/31/2003 | CA2474033A1 Fermentation of pentose sugars |
| 07/31/2003 | CA2474030A1 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
| 07/31/2003 | CA2473944A1 Methods and compositions for rna interference |
| 07/31/2003 | CA2473906A1 Cooperative oligonucleotides |
| 07/31/2003 | CA2473781A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | CA2473744A1 Solid phases optimized for chemiluminescent detection |
| 07/31/2003 | CA2473741A1 A method for generating engineered cells for locus specific gene regulation and analysis |
| 07/31/2003 | CA2473716A1 Alanine 2,3- aminomutase |
| 07/31/2003 | CA2473707A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/31/2003 | CA2473683A1 Signalling aptamer complexes |
| 07/31/2003 | CA2473558A1 Detection of single nucleotide polymorphisms using planar waveguides |
| 07/31/2003 | CA2473555A1 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 07/31/2003 | CA2473474A1 Alteration of rab38 function to modulate mammalian pigmentation |
| 07/31/2003 | CA2473376A1 Method for isolating nucleic acids and protein from a single sample |
| 07/31/2003 | CA2472729A1 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 07/31/2003 | CA2472725A1 Multiply-substituted protease variants |
| 07/31/2003 | CA2472723A1 Multiply-substituted protease variants |
| 07/31/2003 | CA2471967A1 Wt1 antisense oligos for the inhibition of breast cancer |
| 07/31/2003 | CA2469685A1 Bispecific antisense oligonucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same |
| 07/31/2003 | CA2454358A1 Multimeric proteins and methods of making and using same |
| 07/30/2003 | EP1331485A2 Biochemical analysis unit with absorptive zones |
| 07/30/2003 | EP1331484A2 Chemiluminescence method for producing biochemical analysis data and apparatus used therefor |
| 07/30/2003 | EP1331272A1 Novel glucose dehydrogenase and process for producing the dehydrogenase |
| 07/30/2003 | EP1331271A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 07/30/2003 | EP1331270A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 07/30/2003 | EP1331269A1 Novel protein, process for producing the same and use thereof |
| 07/30/2003 | EP1331268A1 Novel proteins, genes encoding them and method of using the same |
| 07/30/2003 | EP1331267A2 Oligonucleotides specific for hepatitis C virus |
| 07/30/2003 | EP1331265A2 density enhanced protein tyrosine phosphatases |
| 07/30/2003 | EP1331228A1 Method of screening antiplatelet |
| 07/30/2003 | EP1331011A2 Derivatized oligonucleotides having improved uptake and other properties |
| 07/30/2003 | EP1330650A2 Method and apparatus for reading reporter labeled beads |
| 07/30/2003 | EP1330645A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 07/30/2003 | EP1330553A1 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
| 07/30/2003 | EP1330552A1 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1 |
| 07/30/2003 | EP1330551A2 Affinity maturation by competitive selection |
| 07/30/2003 | EP1330550A2 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 07/30/2003 | EP1330549A2 Genotyping using partially-complementary probes |
| 07/30/2003 | EP1330548A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 07/30/2003 | EP1330546A2 Method for the amplification and optional characterisation of nucleic acids |
| 07/30/2003 | EP1330545A2 Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis |
| 07/30/2003 | EP1330544A2 Rna aptamers and methods for identifying the same |
| 07/30/2003 | EP1330543A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 07/30/2003 | EP1330539A2 Methods of gene expression monitoring |
| 07/30/2003 | EP1330538A2 Cd36 as a heat shock protein receptor and uses thereof |
| 07/30/2003 | EP1330537A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 07/30/2003 | EP1330535A2 Kini-3 motor protein and methods for its use |
| 07/30/2003 | EP1330532A1 Methods and compositions for directed microwave chemistry |
| 07/30/2003 | EP1330531A2 Influenza virus vector for infection of dendritic cells |
| 07/30/2003 | EP1330530A2 Herbicide-tolerant plants through bypassing metabolic pathway |
| 07/30/2003 | EP1330529A2 Galactosyltransferase homolog, znssp11 |
| 07/30/2003 | EP1330528A2 Regulation of human serine-threonine protein kinase |
| 07/30/2003 | EP1330527A2 Human kinases |
| 07/30/2003 | EP1330526A2 Process for the fermentative preparation of l-amino acids using strains of the enterobacteriaceae family |
| 07/30/2003 | EP1330525A2 Nod2 nucleic acids and proteins |
| 07/30/2003 | EP1330524A2 Novel human 7tm proteins and polynucleotides encoding the same |
| 07/30/2003 | EP1330523A2 Mammalian wnt polypeptide-5 |
| 07/30/2003 | EP1330522A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |